The current price of DHR is $229.35 — it has decreased by 2.38% since the previous close. Data as of Nov 5, 2026.
DHR is down 3.82% over the past week, up 3.68% over the past month and up 8.08% over the past year. The price is above its 200-day moving average of $201.03.
Analysts' average 12-month price target for DHR is $238.77, which implies 4.11% upside from the current price. Individual estimates range from $195.00 to $275.00.
Of the 24 analysts covering Danaher Corporation, 3 rate it a strong buy, 17 rate it a buy and 4 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Danaher Corporation has a market capitalization of $161.23B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Danaher Corporation posted earnings of $2.11 per share against an estimate of $1.92, beating expectations by 9.90%. Upcoming reports are listed in the earnings calendar.
Danaher Corporation reported revenue of $6.55B in its most recent quarter, which has increased by 8.28% compared with the same quarter a year earlier. Analysts had expected $6.56B.
Yes. Danaher Corporation pays dividends quarterly. The latest payment of $0.40 per share has a payment date of Oct 30, 2026, which corresponds to a dividend yield of 0.69%.
Companies most comparable to Danaher Corporation include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Waters Corporation, Mettler-Toledo International Inc. and Illumina, Inc.
In the latest trading session DHR moved between $228.16 and $238.44, a range of 4.48% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Danaher Corporation shows a buy rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks DHR has traded between $160.93 and $242.80. The current price is 5.54% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.